Page last updated: 2024-10-15

acetylcarnitine and Leukemia, Myeloid, Acute

acetylcarnitine has been researched along with Leukemia, Myeloid, Acute in 1 studies

Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research Excerpts

ExcerptRelevanceReference
"Etoposide was also associated with a significant urinary loss of carnitine in mice (~1."1.38Inhibition of OCTN2-mediated transport of carnitine by etoposide. ( Baker, SD; Chen, Z; Hu, C; Hu, S; Lancaster, CS; Rubnitz, JE; Sparreboom, A; Zuo, Z, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, C1
Lancaster, CS1
Zuo, Z1
Hu, S1
Chen, Z1
Rubnitz, JE1
Baker, SD1
Sparreboom, A1

Other Studies

1 other study available for acetylcarnitine and Leukemia, Myeloid, Acute

ArticleYear
Inhibition of OCTN2-mediated transport of carnitine by etoposide.
    Molecular cancer therapeutics, 2012, Volume: 11, Issue:4

    Topics: Acetylcarnitine; Adolescent; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Che

2012